-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZAMEND NEURO ANNOUNCES INITIATION DATE OF FIRST PHASE II CLINICAL TRIAL OF AL001 TO TAKE PLACE AT MASSACHUSETTS GENERAL HOSPITAL

Reuters·02/25/2025 13:00:59

Please log in to view news